THE R3 VASCULAR ADVANTAGE

Technology

R3 Vascular’s novel bioresorbable scaffolds are made from a unique, ultra-high molecular weight polylactic acid polymer. This polymer, combined with our stent design and proprietary processing techniques, allow scaffolds to be thinner, stronger, and more flexible. Our scaffolds are specifically engineered to ensure that they gradually and predictably absorb into the tissue, leaving a more naturally functioning vessel.
magnitude (1).jpg

With the combination of ultra-high molecular weight and carefully designed ratios of amorphous and crystalline domains, resulting scaffolds deliver superior strength, ductility, toughness, and resistance to fracture. The amorphous domain was specifically engineered to ensure that the scaffold undergoes gradual and predictable hydrolysis while maintaining structural integrity during the clinically relevant healing period.

ADVANTAGE

World-class polymer technology, exceptional engineering and design, and unparalleled and flexible manufacturing processes and capabilities are all part of the R3 Vascular advantage. From polymer resin to finished devices, our vertically integrated manufacturing operations offer maximum flexibility and customization. This capability allows us to swiftly iterate and tailor our processes to create scaffolds with unique characteristics for demanding clinical applications.

POLYMER

  • PLLA – proven and safe bioresorbable material

  • Ultra-high Molecular Weight

  • Optimal balance of amorphous and crystalline domains within the polymer structure

RESULTS

  • Exceptional scaffold flexibility allows resistance to fracture and significant conformibility to diametric variability of the vessels

  • High radial strength and circumferential support

  • Balance of strength and ductility

  • Thin, low-profile designs

  • Significant structural stability while polymer undergoes bioresporption

The R3 Vascular BRS, seen above in angiographic and OCT images, shows positive remodeling (late gain) at 1 year follow-up in a BMS overlapping porcine animal study.